Immunological characterization of chimeras of high specificity antigens from Mycobacterium tuberculosis H37Rv
- 1 March 2021
- journal article
- research article
- Published by Elsevier in Tuberculosis
- Vol. 127, 102054
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Role of TNF-Alpha, IFN-Gamma, and IL-10 in the Development of Pulmonary TuberculosisPulmonary Medicine, 2012
- Understanding latent tuberculosis: the key to improved diagnostic and novel treatment strategiesDrug Discovery Today, 2012
- CD8+ T Cells Provide an Immunologic Signature of Tuberculosis in Young ChildrenAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Protection against Tuberculosis in Eurasian Wild Boar Vaccinated with Heat-Inactivated Mycobacterium bovisPLOS ONE, 2011
- Tuberculosis vaccines in clinical trialsExpert Review of Vaccines, 2011
- A Defined Tuberculosis Vaccine Candidate Boosts BCG and Protects Against Multidrug-Resistant Mycobacterium tuberculosisScience Translational Medicine, 2010
- Immunogenicity of Novel DosR Regulon-Encoded Candidate Antigens of Mycobacterium tuberculosis in Three High-Burden Populations in AfricaClinical and Vaccine Immunology, 2009
- Immunisation with BCG and recombinant MVA85A induces long‐lasting, polyfunctional Mycobacterium tuberculosis‐specific CD4+ memory T lymphocyte populationsEuropean Journal of Immunology, 2007
- Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania majorNature Medicine, 2007
- Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectivenessThe Lancet, 2006